Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients

Majority of HIV/HCV Patients Need to Switch Antiretroviral Therapy to Accommodate Direct Acting Antivirals

(2015) Rebecca Cope et al.   AIDS PATIENT CARE AND STDS

Prevalence of Drug–Drug Interactions upon Addition of Simeprevir- or Sofosbuvir-Containing Treatment to Medication Profiles of Patients with HIV and Hepatitis C Coinfection

(2015) Nimish Patel et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Prevalence and Treatment of Chronic Hepatitis C Virus Infection in the US Department of Veterans Affairs

(2015) L. A. Beste et al.   EPIDEMIOLOGIC REVIEWS

Drug interactions with new hepatitis C oral drugs

(2015) Vincent Soriano et al.   Expert Opinion on Drug Metabolism & Toxicology

Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection

(2015) Anu Osinusi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1

(2015) Mark S. Sulkowski et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

(2015) Jean-Michel Molina et al.   LANCET

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

(2014) Eric Lawitz et al.   LANCET

Burden of HIV and hepatitis C co-infection: the changing epidemiology of hepatitis C in HIV-infected patients in France

(2014) Patrice Cacoub et al.   LIVER INTERNATIONAL

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

(2014) Mark S. Sulkowski et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Hepatitis C Cascade of Care among HIV Infected Patients: A Call to Address Ongoing Barriers to Care

(2014) Edward R. Cachay et al.   PLoS One

The Treatment Cascade for Chronic Hepatitis C Virus Infection in the United States: A Systematic Review and Meta-Analysis

(2014) Baligh R. Yehia et al.   PLoS One

Drug interactions between antiretrovirals and new or emerging direct-acting antivirals in HIV/hepatitis C virus coinfection

(2013) Drosos E. Karageorgopoulos et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA

(2013) D Grint et al.   HIV MEDICINE

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial

(2013) Mark Sulkowski et al.   LANCET INFECTIOUS DISEASES

Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C

(2013) Edward J. Gane et al.   NEW ENGLAND JOURNAL OF MEDICINE

Who needs direct acting antivirals for HCV? Challenges faced in advancing HCV therapy for HIV-HCV co-infected persons

(2012) Marina B Klein et al.   ANTIVIRAL THERAPY

HIV/hepatitis C coinfection natural history and disease progression

(2011) Maria D. Hernandez et al.   Current Opinion in HIV and AIDS

HIV/HCV Co-infection: Pathogenesis, Clinical Complications, Treatment, and New Therapeutic Technologies

(2011) Eva A. Operskalski et al.   Current HIV/AIDS Reports

Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: The HEPAIG study

(2010) Lionel Piroth et al.   HEPATOLOGY

Evidence of a Large, International Network of HCV Transmission in HIV-Positive Men Who Have Sex With Men

(2009) Thijis van de Laar et al.   GASTROENTEROLOGY

A large French prospective cohort of HIV-infected patients: the Nadis Cohort

(2009) P Pugliese et al.   HIV MEDICINE

Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis

(2008) Hla-Hla Thein et al.   AIDS